Cannabidiol and epilepsy
Ali, Shayma, Ingrid E. Scheffer, and Lynette G. Sadleir. "Efficacy of cannabinoids in paediatric epilepsy." Developmental Medicine & Child Neurology (2018).
This review provides insights on three clinical trials that showed cannabidiol’s efficacy in reducing seizure episodes by at least 38%. More importantly, this review highlights the need for further research to fully elucidate CBD’s mechanism of action as an antiepileptic which is of utmost importance since the US Food and Drug Administration’s approval of Epidiolex, an antiepileptic drug with cannabidiol (CBD) as the main active ingredient.View This Research